Jack Rose: The Patient Capital Review – a Beginner’s Guide
- On September 1, 2017
- By GrowthInvest Admin
Patient Capital Review – Jack Rose gives the summarising points.
For those of us who work within the tax-advantaged investment sector, the upcoming outcome of the Patient Capital Review (PCR) – all its possible permutations and consequences – is the talk of the town.
But those who spend less time dwelling on tax legislation and rule changes within the sector (very wise if you ask me) are inclined to look blank when you mention the Patient Capital Review.
So for those who like a simple summary of the salient points, click here.
Source: ProfessionalAdviser
GET IN TOUCH!
MAIL US
enquiries@growthinvest.comCALL US
020 7071 3945FOLLOW US ON
Throughout our site you will find links to external websites. Although we make every effort to ensure these links are accurate, up to date and relevant, we cannot take responsibility for pages maintained by external providers.
GrowthInvest is a trading name of EIS Platforms Limited. EIS Platforms Limited (FRN: 694945) is an appointed representative of Sapphire Capital Partners LLP (FRN:565716) which is authorised and regulated by the Financial Conduct Authority in the UK.
All rights reserved 2024 @ growthinvest